2004
DOI: 10.1016/j.ijcard.2003.08.018
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…1,5,19 Increases in short-and long-term mortality have been seen in critically ill patients admitted to the intensive care unit. 31 Highly sensitive troponin assays were recently investigated in the ED setting and are associated with mortality in patients with suspected ischemic chest pain.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…1,5,19 Increases in short-and long-term mortality have been seen in critically ill patients admitted to the intensive care unit. 31 Highly sensitive troponin assays were recently investigated in the ED setting and are associated with mortality in patients with suspected ischemic chest pain.…”
Section: Discussionmentioning
confidence: 99%
“…12,13 Postprocedure troponin positivity has been associated with worse outcomes following percutaneous coronary intervention 14 and both cardiac 15,16 and noncardiac surgery. Although the association of troponin positivity and worse outcomes in patients admitted to hospital is well established, [17][18][19] it is unclear whether this association extends to patients judged to be suitable for discharge from the emergency department (ED). Understanding how troponin positivity affects patient outcomes independently of other clinical variables is imperative when determining appropriate patient disposition and subsequent follow-up.…”
Section: Ré Sumémentioning
confidence: 99%
“…Moreover, troponin elevation of any etiology is associated with increased risk for adverse outcomes. A small study from the Mayo Clinic (Rochester, MN) of patients with elevated troponin levels but non-cardiac diagnoses found a rate of the combined endpoint of death, MI, revascularization, or new-onset heart failure of 36% [16]. Similarly, a TACTICS-TIMI substudy found that among patients with ACS who had no significant CAD at coronary angiography, 3% of patients with troponin elevation died by 6 months versus no deaths in those with normal troponin (P < 0.001) [17].…”
Section: New Developments With Cardiac Troponinsmentioning
confidence: 99%